2010
DOI: 10.1111/j.1755-3768.2008.01465.x
|View full text |Cite
|
Sign up to set email alerts
|

Autosomal dominant pericentral retinal dystrophy caused by a novel missense mutation in the TOPORS gene

Abstract: ABSTRACT.Purpose: This study aimed to identify the genetic cause of autosomal dominant pericentral retinal dystrophy (adPRD) in a large Norwegian family with 35 affected members. Methods: The family was characterized by clinical ophthalmological examination along with fundus photography, dark adaptometry and electroretinography. We performed a genome-wide linkage analysis followed by sequencing of a candidate gene to identify the mutation causing the disease. Results: The ophthalmological examinations revealed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
14
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 22 publications
(15 citation statements)
references
References 18 publications
1
14
0
Order By: Relevance
“…11,12,17 Common to the three studies are data for visual acuities and ERGs. One study was mainly of simplex RP patients with a pericentral distribution of disease.…”
Section: Discussion Comparison With Other Cohorts Of Pericentral Rdmentioning
confidence: 99%
See 4 more Smart Citations
“…11,12,17 Common to the three studies are data for visual acuities and ERGs. One study was mainly of simplex RP patients with a pericentral distribution of disease.…”
Section: Discussion Comparison With Other Cohorts Of Pericentral Rdmentioning
confidence: 99%
“…Five patients from ad pedigrees were screened for mutations in adRP-associated genes through the Carver Laboratory or with APEX microarrays (385 or 414 variants arrays; Asper Ophthalmics). Because the adRP arrays included mutations in RHO and TOPORS, genes previously reported in PRD patients, 12,17 and in RDS, which was causative in one pericentral patient, 33 simplex and multiplex patients who were negative on arRP panels were also screened on the adRP arrays. All patients without a molecular diagnosis were screened for mutations in ABCA4 with APEX microarrays (496, 519, or 577 variants arrays; Asper Ophthalmics), 34 by Carver Laboratory or by Casey Eye Institute Molecular Testing Laboratory (Portland, OR, USA).…”
Section: Molecular Screening Strategymentioning
confidence: 99%
See 3 more Smart Citations